observational studies have documented a large discrepancy
between guideline recommendations and clinical practice,
and a substantial proportion of patients do not achieve the
guidelines target
51-53
. this may be partly explained by poor
patient adherence to treatment. discontinuation of statins is
linked to increased risk of CHd events54, 55
, whereas higher
adherence is associated with lower CHd mortality56-58
. the rate